Naomi Watts is a longtime activist for women's perimenopausal and menopausal health. She spoke to PEOPLE about learning how ...

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product ...

Exclusive distribution agreement includes revenue sharing in addition to upfront and milestone payments to LENZ ...

Launched VIZZ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-November 2025 Achieved approximately $1.6 million in net pr ...

Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in clinical trials ...

LENZ Therapeutics (LENZ) announced an exclusive distribution agreement for Lunatus to register and commercialize VIZZ for the ...

Lake Oswego, OR - January 08, 2026 - PRESSADVANTAGE - At Tersigni Vision, a growing number of patients are asking ...

Opus Genetics (IRD) highlighted its progress achieved during 2025 and upcoming catalysts in 2026. OPGx-BEST1: First ...

Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, today announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its ...

RICHMOND HILL, ON, Jan. 7, 2026 /CNW/ - CooperVision Canada is proud to announce its sponsorship and partnership with Nikita ...

New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl Technology*1 to Slow the Worsening of Myopia ...

K2 Vision markets refractive lens exchange (RLE) as a long-term way to reduce dependence on glasses and readers by replacing ...